Professional Documents
Culture Documents
Consumer Discretionary - 2QFY21 Result Preview - HSIE-202010161813262535535
Consumer Discretionary - 2QFY21 Result Preview - HSIE-202010161813262535535
Consumer Discretionary
No bargains here!
Recovery rates—a mixed bag: Revenue recovery in 2Q is expected to remain
TP
Prev.
choppy as intermittent lockdowns play spoilt sport. While the Paints and Company RECO
(Rs)
TP
(Rs)
Jewellery categories have nearly hit pre-COVID sales, apparel retail
Avenue
continues to struggle as footfalls remain elusive, with recovery rates ranging REDUCE 1,850 1,800
Supermarts
from 30-60%. Grocers, especially the online ones, continue to do well, as Titan SELL 1,050 950
consumers prefer convenience over value. Losses across the board are ABFRL ADD 130 120
ebbing. However, for apparel retailers, profitability improvement remains Trent SELL 500 490
on crutches (rental concessions and salary cuts). In this backdrop, assessing STOP REDUCE 170 170
(1) foregone vs recoverable revenue, (2) inventory position, (3) update on TCNS Clo. REDUCE 370 390
rental negotiations and (4) leverage position remain key.
V-MART ADD 1,850 1,800
Jewellery—hits near pre-COVID sales: Volumes continue to languish Asian Paints REDUCE 1,800 1,800
courtesy elevated gold prices (+40%). However, recovery in value growth is
Berger Paints SELL 460 460
encouraging. Most big-box jewellers’ sales are expected to decline by 0 to -
Kansai Nerolac ADD 500 500
10% in 2Q (channel checks). Assessing ex-pent up demand remains key.
Margins are likely to be weak due to inferior product mix.
Increasing competitive intensity palpable among grocers: Grocers continue
Changes in recommendations
to slug it out to capture a share of the rising online F&G pie (catalysed by the
New Earlier
pandemic). JioMART’s May launch has heightened competition. Along with Company
RECO RECO
intermittent lockdowns, this could impact footfalls for prominent offline
Avenue
discounters like DMART. Margins could be lower than usual as low-margin REDUCE SELL
Supermarts
essential purchases will continue to dominate the grocery basket in 2Q. Titan SELL REDUCE
Apparel recovery remains choppy: Realisations may be weak for most Trent SELL ADD
apparel retailers as this is an EOSS quarter—recovery rates of our universe V-MART ADD BUY
range from 30-60% of pre-COVID levels. Moreover, inventory for almost all
has deteriorated since Mar. Hence, the ask from festive throughput remains Coverage Withdrawal
high. While losses may ebb QoQ as stores are now open, the trajectory of
Company
rental savings could come off directionally, and footfalls are yet to impress.
Paints lead in recovery: Paint firms have hit 100%+ of pre-covid sales as Future Retail
they focus on the less-impacted tier 3/4 cities, low-end emulsions, primers Future Lifestyle Fashions
and putty. The revenues of Top-3 may grow by 2-5%. Margins may expand Arvind Fashion
260-290bp YoY as benign RM-led GM gains trickle down the P&L.
No bargains in the space: While stocks have recovered from their Mar lows,
one would be jumping the gun to call out a secular recovery just yet,
especially in apparel. Upgrades: Avenue Supermarts (SELL to REDUCE),
Downgrades: Titan (REDUCE to SELL), Trent (ADD to SELL) and V-
MART (BUY to ADD).
1QFY21 Sales Gr (%) 2QFY21 Sales Gr (%)
20 4 5 2
-
(2) (4)
(20) (10)
(18) Jay Gandhi
(40) (34)
(43) (46) (42) (40) jay.gandhi@hdfcsec.com
(60) (55)
(59) (62) +91-22-6171-7320
(80) (66)
(70)
(85) (84)
(100) (87) (94) (88)
STOP
Titan
V-MART
KNPL
BRGR
APNT
DMART
TCNS Clo.
ABFRL
Reliance Retail
Trent
Varun Lohchab
varun.lohchab@hdfcsec.com
+91-22-6171-7334
HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters
2QFY21 Results Preview
Retail
2QFY21E
COMPANY WHAT’S LIKELY KEY MONITORABLES
OUTLOOK
The pandemic continues to remain harsh on the Sales velocity and margins.
discounter with 1. Intermittent state lockdowns
playing the spoilt sport, 2. JioMART remaining Pace of network expansion
aggressive on pricing as well as delivery options. Commentary on COVID-led
recovery
Expect D-MART to add 2 stores (net) in 2Q an SSSG
of -12%. Building in revenue per sq. ft of Rs. 26k. Progress on Online strategy.
Avenue
Supermarts
WEAK Gross margins (GMs) however are likely to improve
sequentially as high GM non-essentials.commenced
in 2Q. Expect GMs to improve 40bp to 14.1% QoQ
Building in recovering profitability (EBITDAM 5.7%
in 2QFY21 vs 2.8% in 1Q and 8.7% in 2QFY20)
While recovering, net profits are still likely to fall
short YoY at Rs. 1.92bn.
Titan’s recovery has been better-than-expected. We Sept sales have come off again;
expect net revenue to decline by 2%. Overall EBIT hence commentary on recovery
margin to come off by ~230bp YoY at 7.3% is key and consumer sentiments
Jewellery revenue grew 8.7% YoY (consol) which Outlook on Watches and
includes a Rs. 3.9bn excess gold inventory sale. Ex- Eyewear businesses
that, Jewellery sales have hit near 98% of the base
Titan GOOD Jewellery business EBIT margin
quarter in 2Q. Our forecasts models a 25% decline in
volumes. Expect Jewellery EBIT margins to decline Sept sales have come off again;
190bp YoY to 8.5%. hence commentary on recovery
is key
Watches and Eyewear have recovered to 55/58% of
Pre-COVID sales resp. Inventory levels and capital base
movement in Jewellery
Page | 2
2QFY21 Results Preview
Given the Tier3/4 focus and its value fashion Commentary on supply chain
positioning, V-MART is likely to clock the sharpest recovery
recovery in our apparel retail universe.
Outlook on industry discount
We expect revenue to hit 60% of Pre-COVID sales as levels post COVID-19 lockdown
consumers return to stores for their need-based
purchases. Avg order values and Articles per order Inventory and creditor levels
remain high, implying, footfall recovery remains Trajectory of rental savings.
lower than revenue recovery.
V-MART GOOD
Building in 2 store additions for the quarter.
Recovery for TCNS has remained amongst the Outlook on industry discount
weakest within our universe. We build in a decline levels post COVID-19 lockdown
of 66% YoY in 2Q as intermittent state lockdowns
impact footfalls. We build in revenue declines of Inventory and debtor levels
across -75/-75/-80/0% EBOs/LFS/MBOs/Online Commentary on rental re-
channels resp. negotiations
Inventory is expected to be higher than the already Strategy on liquidating
TCNS Clothing WEAK elevated March levels. Ergo, pricing power during inventory without material
the unlock phase and leading to the festive season is write-offs
expected to be weak.
Page | 3
2QFY21 Results Preview
Paints
2QFY21E WHAT’S LIKELY KEY MONITORABLES
COMPANY
OUTLOOK
We expect a full recovery in the anchor biz - Recovery trajectory in October
decorative paints in 2Q (and ~10% volume growth
(vs ~38% decline in 1Q). Rebating and discounting trends
Channel checks suggest that East followed by North Dealer addition trajectory
and South have progressively picked up while West
lags the recovery curve.
Berger to marginally outpace APNT given its higher Recovery trajectory in October
exposure to the less impacted Tier 2/3 and
North/East focus. Rebating and discounting trends
We build in ~5% YoY growth in standalone biz. (+9/- Dealer addition trajectory
4% volume/realization growth)
Page | 4
2QFY21 Results Preview
Note: Growth in decorative paints comes off a weak Dealer addition trajectory
base as KNPL’s top-line was impacted due to the
J&K curfew following revocation of Article 370 in
Aug 2019 in the base quarter (A key catchment). We
estimate +8%/-4% volume/realization growth in
decorative biz. Auto coatings segment is likely to
Kansai Nerolac
recover mimicking that of the client base.
Estimate Changes
Avenue Supermarts
FY21E FY22E FY23E
(Rs mn) Change Change Change
New Old New Old New Old
(%) (%) (%)
Revenue 249,353 259,978 (4.1) 351,654 349,596 0.6 351,654 349,596 0.6
Gross Profit 35,710 36,440 (2.0) 52,741 52,434 0.6 52,741 52,434 0.6
Gross Profit Margin (%) 14.3 14.0 30 bps 15.0 15.0 (0 bps) 15.0 15.0 (0 bps)
EBITDA 18,001 18,940 (5.0) 30,414 30,279 0.4 30,414 30,279 0.4
EBITDA margin (%) 7.2 7.3 (7 bps) 8.6 8.7 (1 bps) 8.6 8.7 (1 bps)
APAT 11,755 12,800 (8.2) 20,418 20,716 (1.4) 20,418 20,716 (1.4)
APAT margin (%) 4.7 4.9 (21 bps) 5.8 5.9 (12 bps) 5.8 5.9 (12 bps)
EPS (Rs) 18.1 19.8 (8.2) 31.5 32.0 (1.4) 31.5 32.0 (1.4)
Page | 5
2QFY21 Results Preview
Financial Summary
NET SALES (Rs bn) EBITDA (Rs bn) EBITDA margin (%) APAT (Rs bn)
Company 2Q QoQ YoY 2Q QoQ YoY 2Q QoQ YoY 2Q QoQ YoY
FY21E (%) (%) FY21E (%) (%) FY21E (bps) (bps) FY21E (%) (%)
Food & Grocery
Avenue Supermarts 53.4 39.3 (10.2) 3.1 182 (40) 5.7 291 (291) 1.9 NM NM
Jewellery
Titan 45.7 130.8 (2.0) 4.3 NM (18) 9.3 NM (185) 2.3 NM NM
Apparel
ABFRL 10.4 224.9 (55.0) (1.5) NM (143) (14.1) NM (2,876) (3.1) NM NM
Trent 4.7 389.8 (42.3) 0.6 NM (57) 12.2 NM (409) (0.3) NM NM
STOP 2.5 370.3 (70.0) (0.3) NM (122) (12.0) NM (2,823) (0.7) NM NM
TCNS Clothing 1.1 238.8 (65.8) (0.4) NM (156) (33.0) NM (5,328) (0.4) NM NM
V-MART 1.9 141.5 (40.0) - NM (100) - NM (360) (0.3) NM NM
Paints
Asian Paints 52.4 79.2 3.7 11.3 133.0 18 21.5 497 264 7,254 230 (14)
Berger Paints 16.8 80.7 5.2 3.0 230.4 21 18.1 820 238 1,800 1,093 (8)
Kansai Nerolac 12.7 112.9 2.4 2.5 216.0 19 20.0 652 286 1,770 315 (8)
Valuation Summary
Mcap EPS (Rs) P/E (x) EV/EBITDA (x) Core ROCE (%)
CMP TP
Company (Rs Reco.
(Rs) (Rs) FY21E FY22E FY23E FY21E FY22E FY23E FY21E FY22E FY23E FY21E FY22E FY23E
bn)
Avenue Supermarts 1,247 1,975 REDUCE 1850 18.8 32.7 39.1 104.9 60.4 50.5 69.2 40.9 32.2 12.4 19.3 19.5
Titan 1,089 1,231 SELL 1050 8.5 18.9 23.4 146.7 66.1 53.3 76.1 42.2 35.2 7.8 15.6 17.5
ABFRL 104 135 ADD 130 -10.9 -6.1 -5.5 -11.8 -21.0 -23.2 -380.6 13.0 10.9 -24.3 -5.7 -6.3
Trent 235 663 SELL 500 0.3 3.4 3.3 NM NM NM 59.0 39.5 34.7 2.9 5.8 5.7
STOP 15 173 REDUCE 170 -14.3 -4.3 -1.2 NM NM NM -31.1 8.5 6.2 -18.2 -7.1 -2.3
TCNS Clothing 23 379 REDUCE 370 -10.3 8.0 10.5 -33.2 42.7 32.6 -19.9 25.1 17.5 -22.9 10.4 12.7
V-MART 35 1,931 ADD 1850 20.9 43.3 53.3 85.3 41.3 33.5 36.4 21.9 17.7 8.4 17.6 19.2
Asian Paints 1,993 2,078 REDUCE 1800 25.2 33.4 37.7 77.5 58.6 51.9 48.0 38.0 34.5 23.5 31.5 35.0
Berger Paints 587 606 SELL 460 6.0 7.9 8.9 100.0 76.2 67.6 60.5 47.2 41.7 17.6 21.5 22.1
Kansai Nerolac 264 490 ADD 500 7.9 10.6 11.9 61.9 46.4 41.2 36.6 28.6 25.4 10.7 13.8 14.0
Source: HSIE Research
Page | 6
2QFY21 Results Preview
Rating Criteria
BUY: >+15% return potential
ADD: +5% to +15% return potential
REDUCE: -10% to +5% return potential
SELL: > 10% Downside return potential
Disclosure:
We, Jay Gandhi, MBA & Varun Lohchab, PGDM, authors and the names subscribed to this report, hereby certify that all of the views expressed in this
research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of
publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or
view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative
or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding
the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material
conflict of interest.
Any holding in stock –No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must not be used as a singular basis of any
investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor;
readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this
document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in securities of the companies
referred to in this document (including merits and risks) and should consult their own advisors to determine merits and risks of such investment. The
information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be
reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,
completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any company or companies or their
securities mentioned herein are not intended to be complete. HSL is not obliged to update this report for such changes. HSL has the right to make changes and
modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen
or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be
contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the same should be ignored and brought to
the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any purposes or in
any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or
price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively
assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report
should not be construed as an invitation or solicitation to do business with HSL. HSL may from time to time solicit from, or perform broking, or other services
for, any company mentioned in this mail and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of
the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a
market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any
other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments
made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates,
diminution in the NAVs, reduction in the dividend or income, etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt
in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations
described in this report.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject
company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the
date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage
services or other advisory service in a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with
preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this
report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may
have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of
the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg
(East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022)
3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018;
IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN -
U67120MH2000PLC152193
HDFC securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board: +91-22-6171-7330 www.hdfcsec.com
Page | 7